Breast tumor overexpression of FAS has also long been recognized as an indicator of poor clinical prognosis [66], lending greater public health importance to the hypothesis that trans fatty acids may increase the risk of breast cancers with high FAS expression. The gene discussed is FAS; the disease is breast carcinoma.